An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma
Zhejiang University
Zhejiang University
Shandong Provincial Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Royal Marsden NHS Foundation Trust
Ruijin Hospital
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Göttingen
National Cancer Institute (NCI)
National Cancer Institute (NCI)